GSK‐3β inhibitor TDZD‐8 reduces neonatal hypoxic‐ischemic brain injury in mice

AIMS: Glycogen synthase kinase 3β (GSK‐3β) is activated following hypoxic‐ischemic (HI) brain injury. TDZD‐8 is a specific GSK‐3β inhibitor. Currently, the impact of inhibiting GSK‐3β in neonatal HI injury is unknown. We aimed to investigate the effect of TDZD‐8 following neonatal HI brain injury. M...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:CNS Neurosci Ther
Main Authors: Huang, Sammen, Wang, Haitao, Turlova, Ekaterina, Abussaud, Ahmed, Ji, Xiang, Britto, Luiz R., Miller, Steven P., Martinez, Ana, Sun, Hong‐Shuo, Feng, Zhong‐Ping
Format: Artigo
Sprog:Inglês
Udgivet: John Wiley and Sons Inc. 2017
Fag:
Original Articles
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6492674/
https://ncbi.nlm.nih.gov/pubmed/28256059
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cns.12683
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker